Ledger.Open graph →
SEC Form D · filed September 23, 2014

OnCore Biopharma, Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DOYLESTOWN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

P. S. Price · Doylestown, PADirectorMichael Mcelhaugh · Doylestown, PAExecVivek S. Ramaswamy · Doylestown, PADirectorBryce Roberts · San Francisco, CAExecPatrick Higgins · Doylestown, PAExec · DirectorMichael Sofia · Doylestown, PAExecWilliam S. Symonds · Doylestown, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗